UN removes cannabis from list of most dangerous substances Thursday, 28 January 2021
The United Nations Commission on Narcotic Drugs (CND) has voted to remove cannabis from the list of the most dangerous substance.
According to the UN news portal, in reviewing a series of World Health Organisation (WHO) recommendations on cannabis and its derivatives, CND zeroed in on the decision to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs.
Under the schedule, cannabis was listed alongside specific deadly, addictive opioids, including heroin, recognised as having little to no therapeutic purpose.
“The 53 member states of the CND, the UN’s central drug policy making body, voted to remove cannabis from that schedule where it had been placed for 59 years and to which the strictest control measures apply that generally discouraged its use for medical purposes,” reads the information on the UN news portal.
La lutte contre le trafic de drogue nuit-elle aux politiques de développement ? theconversation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theconversation.com Daily Mail and Mail on Sunday newspapers.
Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
The United Nations got the ball rolling with global decriminalization of marijuana last year with the rescheduling of the plant in its Single Convention on Narcotic Drugs at least, in theory.
In this video clip from
Motley Fool Live, healthcare and cannabis bureau chief Corinne Cardina discusses this move and its potential impact with longtime Fool contributor Eric Volkman. This video was recorded on Dec. 22, 2020.
ProHealth
By Donna Gregory Burch • ProHealth.com • January 25, 2021
(
>2020 was a quiet year for the fibromyalgia community when compared to Lyme or ME/CFS. There were no major headlines, and yet thousands of researchers, physicians and advocates worked behind the scenes, inching toward better treatments, testing and quality of life for fibromyalgia patients.
Below is a summary of some of the most important fibromyalgia-related news stories from the past year. These small but mighty advances should lead to even more progress during 2021.
New Fibromyalgia Drugs Are in the Pipeline
NYX-2925:
In September, biopharmaceutical company Aptinyx, Inc. resumed patient recruitment for a phase 2 study of NYX-2925, a novel N-methyl-D-aspartate receptor modulator, after temporarily halting the trial in March due to the COVID-19 pandemic.
Is cannabis safe for pregnant women to use?
Is there a danger to secondhand cannabis smoke?
Does cannabis use clash with other medications?
All of these are fairly straightforward questions which should be straightforward to study, but not in the nascent grey industry that is legal cannabis.
Scientifically speaking, we know more about the effects of cow flatulence on the atmosphere than the effects of cannabis on the human body.
If the cannabis industry is to ever be taken seriously on the international stage, there’s a desperate need for research from respected scientists and doctors and less anecdotal input from Jeff the Budtender.